| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.3M | +11.9% |
| SG&A Expense | $12.7M | -0.1% |
| Pre-tax Income | -$116.5M | -32.5% |
| Income Tax | $0 | — |
| Net Income | -$116.5M | -32.5% |
| EPS (Basic) | -$4.73 | +23.2% |
| EPS (Diluted) | -$4.73 | +23.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -91.8% |
| Short-term Investments | $46.5M | — |
| Current Assets | $56.1M | -5.7% |
| Total Assets | $89.1M | -4.0% |
| Current Liabilities | $3.9M | -39.8% |
| Total Liabilities | $81.9M | +850.7% |
| Stockholders' Equity | $7.2M | -91.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.5M | -39.1% |
| Investing Cash Flow | -$45.3M | — |
| Financing Cash Flow | $33.0M | — |